Lysogene is a global leader in the research and clinical development of gene therapy for neurodegenerative disorders. Our mission is to radically improve the health of patients suffering from incurable life threatening conditions. We do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.
http://www.lysogene.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.6 seconds
Karen Aiach
Karen Aiach
10 AVE●●●●●●HEGUDE
NAN●●●RRE , FR, 92000
FR
View this contact
VIADUC
Mickael ESNAULT
09 rue●●●●●●s Watt
BEA●●●UZE , 49070
FR
View this contact
VIADUC
Mickael ESNAULT
09 rue●●●●●●s Watt
BEA●●●UZE , 49070
FR
View this contact
BUY YOUR DOMAIN
14
YEARS
11
MONTHS
21
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
19
SSL
EXTERNAL LINKS
41
SITE IP
5.135.223.154
LOAD TIME
0.644 sec
SCORE
6.2
LYSOGENE - Biotechnology company in the field of gene therapy | lysogene.com Reviews
https://lysogene.com
Lysogene is a global leader in the research and clinical development of gene therapy for neurodegenerative disorders. Our mission is to radically improve the health of patients suffering from incurable life threatening conditions. We do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.
lysogene.com
LYSOGENE - Expertise
http://www.lysogene.com/about/expertise
Understanding CNS gene therapy. Lysogene continues to make extraordinary progress and has nurtured meaningful relationships with key stakeholders worldwide. Its unparalleled expertise covers the cutting edge and relevant areas of gene therapy and orphan drug development:. We have a thorough understanding of viral gene transfer and the design of therapeutic vectors suitable for clinical development. Specialist regulatory affairs expertise:. Lysogene CEO Karen Aiach featured in SuperHuman: The Promise of G...
LYSOGENE - News
http://www.lysogene.com/media-center/news
Understanding CNS gene therapy. 14th INTERNATIONAL SYMPOSIUM ON MPS AND RELATED DISEASES. Lysogene Appoints Dr. Kimberley S. Gannon as Chief Scientific Officer. Karen Aiach, CEO of Lysogene, to Deliver Keynote, Rare Informs the Common at Precision Medicine 2016: Rogue Therapeutics Conference. European Conference on Rare Diseases and Orphan Products (ECRD). Lysogene to Host First Ever Research Symposium Dedicated to GM-1 Gangliosidosis. Lysogene creates a Medical and Regulatory Department.
LYSOGENE - Management Team
http://www.lysogene.com/about/management-team
Understanding CNS gene therapy. Founder, Chief Executive Officer. Ms Aiach graduated from the ESSEC Business School and majored in Economics. Kimberley S. Gannon. Dr Gannon received her PhD in Neuroscience from Florida State University and conducted her postdoctoral training at the Roche Institute of Molecular Biology, Hoffmann-LaRoche Inc., in New Jersey and at Mount Sinai School of Medicine in the Department of Physiology and Biophysics in New York. Senior Vice President and Chief Medical Officer.
LYSOGENE - In the Media
http://www.lysogene.com/media-center/in-the-media
Understanding CNS gene therapy. The Promise of Gene Therapy - 15 August 2016. KAREN AIACH KEYNOTE SPEECH AT HARVARD PRECISION MEDICINE CONFERENCE 2016. Rare Informs the Common - 15 July 2016. MOM-ENTREPRENEUR FORMS GENE THERAPY COMPANY TO TACKLE SANFILIPPO SYNDROME. Vector - 5 July 2016. Q and A WITH RARE DISEASE MOM AND BIOTECH CEO KAREN AIACH. Boston Business Journal - 23 June 2016. ALL IN THE FAMILY. Scientific American World View - 21 June 2016. LYSOGENE IS ONE OF 15 AWESOME BIOTECHS TO KNOW IN PARIS.
LYSOGENE - Links and resources
http://www.lysogene.com/patients-and-families/links-and-resources
Understanding CNS gene therapy. A list of patient organizations, other links and resources is provided on the MPS society website. And on the international MPS Network website. Other general links includes:. Alliance for Regenerative Médicine. Lysogene CEO Karen Aiach featured in SuperHuman: The Promise of Gene Therapy https:/ t.co/845Ymcoji3. Join our mailing list.
TOTAL PAGES IN THIS WEBSITE
19
Génterápia - Vállalatok. A legjobb válaszok profiktól.
http://genterapia.lap.hu/vallalatok/25636027
Legyen a Startlap a kezdőlapom. Http:/ genterapia.lap.hu/. Advanced Cell and Gene Therapy (USA). Ezt a linket add a Startlaphoz! Amsterdam Molecular Therapeutics (NL). Ezt a linket add a Startlaphoz! BTX Harvard Apparatus (USA). Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Copernicus Therapeutics, Inc. (USA). Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Gene Ｍedicine Japan Inc. (JP). Ezt a linket add a Startlaphoz! VirRx, Inc. (USA).
Thérapie génique • Sanfilippo | Laurine Moreau • Illustration Scientifique
http://laurinemoreau.com/projets-majeurs/therapie-genique-sanfilippo
Faune & Flore. Thérapie Génique – Sanfilippo. Mots clés : multimédia. Projets réalisés durant un stage de deux mois chez Lysogene. Une entreprise de biotechnologie spécialisée dans le développement de thérapies géniques. Intracérébrales visant à traiter les maladies lysosomales à atteinte du système nerveux central. Première cause de mortalité neurodégénérative chez l’enfant. Aussi connue sous le nom de syndrome de Sanfilippo. Ci-dessous : application multimédia. Ci-dessous : illustrations et posters.
Bioprocess - Biotechs Pharma Actualités
http://www.biotechsactualites.com/bioprocess
Dimanche 21 août 2016. Lonza ouvre ses portes (cliquez ici). Le champion mondial de la bioproduction à façon propose une visite virtuelle à 360 de l’ensemble de ses sites de recherche et de bioproduction à travers dans le monde. Centre d’Immunologie Pierre Fabre. Genzyme, groupe Sanofi. Le nouveau Biostat A de Sartorius Stedim Biotech veut séduire tous les utilisateurs. Crédit : Lonza Group Ltd. 3C France veut améliorer les conditions de la culture des micro organismes. 00 33 (0)1 81 59 09 54.
Pegasus SV4 de Pall Life Sciences pour une meilleure rétention et élimination des parvovirus - Biotechs Pharma Actualités
http://www.biotechsactualites.com/actualites/article/pall-lance-un-nouveau-filtre
Dimanche 21 août 2016. TxCell publie ses résultats du 1er trimestre 2016. La Technopôle CBS organisera sa 6ème édition du Outsource Drug Development à Evreux. L’association ELRIG présentera les 3 et 4 mai à Rennes sa conférence annuelle dédiée à l’automatisation formulation et criblage phénotypique. Http:/ www.elrigfr.org/elrig-fr-conference/. Genzyme, a Sanofi Company. Ernst and Young publie son étude sur le secteur des biotechnologies Beyond Borders Global Biotechnology report 2013.
Fortébio veut accélérer la recherche dans les biothérapies grâce à de nouveaux biocapteurs - Biotechs Pharma Actualités
http://www.biotechsactualites.com/actualites/article/fortebio-veut-accelerer-la-52
Dimanche 21 août 2016. TxCell publie ses résultats du 1er trimestre 2016. La Technopôle CBS organisera sa 6ème édition du Outsource Drug Development à Evreux. L’association ELRIG présentera les 3 et 4 mai à Rennes sa conférence annuelle dédiée à l’automatisation formulation et criblage phénotypique. Http:/ www.elrigfr.org/elrig-fr-conference/. Genzyme, a Sanofi Company. Ernst and Young publie son étude sur le secteur des biotechnologies Beyond Borders Global Biotechnology report 2013.
Techniques R&D - Biotechs Pharma Actualités
http://www.biotechsactualites.com/techniques-de-r-d
Dimanche 21 août 2016. Fortébio veut accélérer la recherche dans les biothérapies grâce à des biocapteurs anti-Fab-CH1 humain. La société FortéBio (division de Pall Life Sciences), spécialisée dans les technologies d’analyse sans marquage, annonce le lancement de son biocapteur anti-Fab-CH1 humain Dip and Read (plonger et lire pour tester) pour les analyses rapides de quantification, de cinétique et d’affinité des (.). La société mayennaise Awel obtient la certification UL pour le marché nord américain.
The Pipeline – Jonah's Just Begun
http://jonahsjustbegun.org/the-pipeline
Jonah’s Just Begun. Jill Wood’s Personal Blog. What is H.A.N.D.S? Levi’s Life, Love & Laughter. Le combat de Haïtem contre Sanfilippo. Released November 26 2013. Stem Cell and Neurotherapies Group, Centre for Genomic Medicine, University of Manchester Willink Biochemical Genetics Unit, Centre for Genomic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust. To read the entire press release click HERE. Visit the Lysogene website for complete details. Shire Enters into...
Role of patient in rare disease research and orphan drug development | Rare disease matters
http://www.rarediseasematters.org/role-of-patient
Recognizing and understanding the value of patient-driven innovation. Why Rare disease matters. Patient-initiated research foundations: A source of funding, but more importantly a continuous source of inspiration. Nowadays, the role of rare disease patients in rare disease research and orphan drug development is enormous and at all stages of the drug innovation cycle: from bench to bed and from bed to bench. In the US as well as EU an orphan designation has been granted for the product. Finally, the AKUs...
Rare disease advocates moving into biotech | Rare disease matters
http://www.rarediseasematters.org/2014/04/rare-disease-advocates-moving-into-biotech
Recognizing and understanding the value of patient-driven innovation. Why Rare disease matters. Patient-initiated research foundations: A source of funding, but more importantly a continuous source of inspiration. Importance rare disease patient advocacy recognized in scientific literature. Regulators move patient engagement to the next level: benefit-risk assessment →. Rare disease advocates moving into biotech. Therapy developed by patients for patients. 8220; They are not the only ones…. The most well...
Sanfilippo Portugal - TRATAMENTOS/ENSAIOS CLÍNICOS
http://www.sanfilippoportugal.com/index.php/sanfilippo-menu/tratamentos-ensaios-clinicos
Informação acerca dos programas de investigação que estão em fase de ensaio clínico ou prestes a entrar nela. Desde que a doença foi descrita pela primeira vez pelo médico americano Sylvester Sanfilippo em 1963, já bastante se avançou no sentido de uma melhor compreensão da patologia, bem como na investigação de abordagens terapêuticas eficazes. Embora o espaço de tempo necessário para levar um produto terapêutico da investigação à clínica seja bastante longo, uma aceleração enorme neste prazo foi conseg...
TOTAL LINKS TO THIS WEBSITE
41
洛阳国际科技创新产业园
网站访问报错
lysoftware.net
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
Big North Lodge | Big North Lodge and Outposts Minaki Winnipieg River Fishing Lodge Ontario
Accommodations available in a remote, private and peaceful setting on the mainland at Minaki on the Winnipeg River System. Walleye, northern pike, smallmouth bass and muskie fishing as well as great white tailed deer, black bear and moose hunting. Fishing at Big North Lodge starts right from our docks. Throughout the season, from May to October, fishing is excellent for Walleye, Northern Pike,. Bass and there is the ever elusive Muskie. Enjoy some of the best whitetail deer hunting in Northwestern Ontario.
Hosted By One.com | Webhosting made simple
Domain and Cheap Web Hosting by One.com. Lysogdesign.no is hosted by One.com. Web hosting and domain by One.com. Affordable web hosting and domain plans available at One.com. Build your own website with Website Builder or choose a 1-click blog installation. Whatever you choose, One.com. Is dedicated to our customers' satisfaction with 24/7 chat support.
LYSOGENE - Biotechnology company in the field of gene therapy
On the cutting edge of. CNS gene therapy science. Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders . Our mission is to radically improve the health of patients suffering from incurable life threatening conditions. We do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system. Lysogene: 2017 annual results. Join our mailing list.
Forside - LYS&FARVELYS&FARVE | Malerarbejde
Malermester Flemming Jensen mener det er håndværket,. Der er i centrum, og han har fundet en niche med de gamle teknikker. Lys and Farve er et relativt nyt malerfirma og dog med 40 års erfaring bag sig. Ådring, marmorering, forgyldning, fresco, historisk håndværk, kalkning, limfarver, traditionelt malerarbejde, linolie. Se vores mange referencer fra vores glade og tilfredse kunder og bliv inspireret til dit næste projekt. Kontakt os i dag og modtag allerede et uforpligtende tilbud på din næste opgave.
Velkommen til Lys og farver
Lys & Form
Lys og Fraktaler | Light for disaster areas
Light for disaster areas. On August 4, 2010. Med projektperioden der sluttede i starten af Juni og eksamenerne veloverstået kom vores projekt på Designskolen Koldings Afgangsudstilling på museet Trapholt i Kolding. 4 plakater der beskriver Aurora, Trapholt. Vi arbejder nu med at finde en partner så vi kan arbejde videre med projektet og få det realiseret. Aurora, model i 1:3. Det har været fantastisk at opleve den entusiasme, og hjælpsomhed som alle vores samarbejdspartner har udvist. On June 17, 2010.
Hyggelys | – Stearinlys til hverdag og fest
8211; Stearinlys til hverdag og fest. Praktisk info / Betaling. Mussel malet lys og servietter. Pynt til lys og bord.
SOCIAL ENGAGEMENT